ESC 365 - Could combination therapy become the first step to achieving LDL-C goals in high- and very high-risk patients?

Open Access

Could combination therapy become the first step to achieving LDL-C goals in high- and very high-risk patients?

Session: Combination therapy at the heart of lipid lowering management

Topic: Lipid-Lowering Agents

Speaker: Doctor C. Escobar Cervantes (Madrid, ES)

Sponsored by Daiichi Sankyo Europe GmbH

Event: ESC Preventive Cardiology 2023

Congress Presentation

About the speaker

Doctor Carlos Escobar Cervantes

La Paz University Hospital, Madrid (Spain)

3 presentations

0 follower

4 more presentations in this session

Welcome and introduction.

Speaker: Professor A. Catapano (Milan, IT)

Lipid lowering therapies for cardiovascular risk reduction and LDL-C goal achievement

Speaker: Doctor L. Perez De Isla (Madrid, ES)

Panel discussion and Q&A

Speaker: Professor A. Catapano (Milan, IT) Doctor C. Escobar Cervantes (Madrid, ES) Doctor L. Perez De Isla (Madrid, ES)

Closing remarks

Speaker: Professor A. Catapano (Milan, IT)

Access the full session

Combination therapy at the heart of lipid lowering management

Speakers: Doctor C. Escobar Cervantes, Professor A. Catapano, Doctor L. Perez De Isla, Professor A. Catapano, Doctor C. Escobar Cervantes...

About the event

ESC Preventive Cardiology 2023

13 April - 15 April 2023

Sessions Presentations

Congress

ESC 365 is supported by